Correlation Between AptaBio Therapeutics and Hyundai Engineering

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and Hyundai Engineering at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and Hyundai Engineering into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AptaBio Therapeutics and Hyundai Engineering Plastics, you can compare the effects of market volatilities on AptaBio Therapeutics and Hyundai Engineering and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of Hyundai Engineering. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and Hyundai Engineering.

Diversification Opportunities for AptaBio Therapeutics and Hyundai Engineering

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between AptaBio and Hyundai is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and Hyundai Engineering Plastics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hyundai Engineering and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with Hyundai Engineering. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hyundai Engineering has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and Hyundai Engineering go up and down completely randomly.

Pair Corralation between AptaBio Therapeutics and Hyundai Engineering

Assuming the 90 days trading horizon AptaBio Therapeutics is expected to generate 2.66 times more return on investment than Hyundai Engineering. However, AptaBio Therapeutics is 2.66 times more volatile than Hyundai Engineering Plastics. It trades about 0.0 of its potential returns per unit of risk. Hyundai Engineering Plastics is currently generating about -0.05 per unit of risk. If you would invest  805,000  in AptaBio Therapeutics on August 25, 2024 and sell it today you would lose (177,000) from holding AptaBio Therapeutics or give up 21.99% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

AptaBio Therapeutics  vs.  Hyundai Engineering Plastics

 Performance 
       Timeline  
AptaBio Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Hyundai Engineering 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hyundai Engineering Plastics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

AptaBio Therapeutics and Hyundai Engineering Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AptaBio Therapeutics and Hyundai Engineering

The main advantage of trading using opposite AptaBio Therapeutics and Hyundai Engineering positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, Hyundai Engineering can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hyundai Engineering will offset losses from the drop in Hyundai Engineering's long position.
The idea behind AptaBio Therapeutics and Hyundai Engineering Plastics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world